Insider Shareholders with Direct Ownership of Avantor, Inc. (AVTR)
This section provides a comprehensive overview of the insiders with direct ownership of Avantor, Inc. (AVTR). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Avantor, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Michael Stubblefield
President & CEO |
2,250,277 | 2,141,069 | 1,111,751 $24.9 Million | 35 |
Feb 25, 2024
Reduced 0.69%
|
|
Rajiv Gupta
Director |
8,451 | 568,605 | 780,562 $17.5 Million | 8 |
Apr 01, 2022
Added 0.16%
|
|
Jonathan M Peacock
Director |
33,429 | 0 | 194,624 $4.35 Million | 5 |
May 09, 2024
Added 4.17%
|
|
Frederic Vanderhaegen
EVP, Americas and Europe |
176,368 | 255,997 | 160,735 $3.6 Million | 24 |
Aug 25, 2023
Reduced 13.46%
|
|
Devashish Ohri
EVP, IMEA |
411,800 | 424,376 | 139,095 $3.11 Million | 17 |
May 27, 2021
Reduced 41.82%
|
|
James Bramwell
EVP Sales, Customer Excellence |
53,700 | 94,282 | 96,233 $2.15 Million | 22 |
Feb 29, 2024
Reduced 4.85%
|
|
Michael Wondrasch
EVP & CIO |
48,140 | 100,812 | 96,072 $2.15 Million | 10 |
Feb 20, 2023
Reduced 1.39%
|
|
Justin Miller
EVP & General Counsel |
150,896 | 173,820 | 93,336 $2.09 Million | 17 |
May 17, 2023
Reduced 11.77%
|
|
Jo Natauri
Director |
92,661 | 0 | 92,661 $2.07 Million | 1 |
May 11, 2021
Added 50.0%
|
|
Gerard Brophy
EVP, Biopharma Production |
688,746 | 796,297 | 89,032 $1.99 Million | 36 |
May 17, 2023
Reduced 18.11%
|
|
Thomas A Szlosek
EVP & CFO |
108,877 | 135,957 | 77,489 $1.73 Million | 17 |
May 17, 2023
Reduced 23.09%
|
|
Christophe Couturier
EVP, AMEA |
165,886 | 258,797 | 73,930 $1.65 Million | 43 |
Jul 31, 2024
Reduced 0.14%
|
|
Sheri Lewis
EVP, Global Ops & Supply Chain |
88,860 | 18,171 | 70,692 $1.58 Million | 10 |
Dec 31, 2023
Reduced 6.05%
|
|
Randy Lee Stone
EVP, Laboratory Solutions |
73,999 | 6,762 | 68,105 $1.52 Million | 3 |
Apr 16, 2024
Reduced 9.03%
|
|
Juan Andres
Director |
33,429 | 0 | 48,380 $1.08 Million | 5 |
May 09, 2024
Added 14.91%
|
|
Michael Severino
Director |
33,429 | 0 | 43,451 $971,998 | 5 |
May 09, 2024
Added 16.32%
|
|
Kitty Sahin
EVP, Strategy&Corp Development |
24,505 | 8,921 | 42,274 $945,669 | 5 |
Jul 18, 2024
Reduced 8.51%
|
|
Benoit Gourdier
EVP, Bioscience Production |
42,453 | 1,263 | 41,190 $921,420 | 3 |
Oct 02, 2024
Reduced 2.98%
|
|
Gregory L Summe
Director |
33,429 | 0 | 41,011 $917,416 | 5 |
May 09, 2024
Added 17.13%
|
|
Meghan Henson
EVP, Chief HR Officer |
46,398 | 6,214 | 40,184 $898,916 | 9 |
Feb 25, 2023
Reduced 1.95%
|
|
Claudius Sokenu
EVP, Chief Legal & Compliance |
42,080 | 3,122 | 38,958 $871,490 | 3 |
Jul 24, 2024
Reduced 7.42%
|
|
Christi Shaw
Director |
24,952 | 14,286 | 36,271 $811,382 | 5 |
May 11, 2023
Added 21.29%
|
|
Brittany Hankamer
EVP, Chief HR Officer |
11,293 | 2,005 | 34,786 $778,162 | 7 |
Aug 14, 2024
Reduced 0.51%
|
|
Rakesh Sachdev
Director |
7,236 | 0 | 32,841 $734,653 | 1 |
Feb 25, 2021
Added 18.06%
|
|
Lan Kang
Director |
30,215 | 0 | 30,215 $675,909 | 5 |
May 09, 2024
Added 21.91%
|
|
Steven W Eck
SVP & Chief Accounting Officer |
51,474 | 45,391 | 29,544 $660,899 | 26 |
Sep 05, 2024
Reduced 10.66%
|
|
John Carethers
Director |
28,758 | 0 | 28,758 $643,316 | 5 |
May 09, 2024
Added 22.77%
|
|
Corey Walker
President Laboratory Solutions |
28,254 | 0 | 28,254 $632,041 | 1 |
Jun 21, 2024
Added 50.0%
|
|
Mala Murthy
Director |
27,109 | 0 | 27,109 $606,428 | 5 |
May 09, 2024
Added 23.82%
|
|
Joseph R Massaro
Director |
26,938 | 0 | 26,938 $602,603 | 5 |
May 09, 2024
Added 23.94%
|
|
R. Brent Jones
EVP, Chief Financial Officer |
25,667 | 0 | 25,667 $574,170 | 1 |
Feb 23, 2024
Added 50.0%
|
|
Sven Henrichwark
EVP, APAC Region |
5,427 | 0 | 19,802 $442,970 | 1 |
Feb 25, 2021
Added 21.51%
|
|
Mark Christopher Murray
EVP, Biomaterials & AT |
8,140 | 1,836 | 18,680 $417,871 | 3 |
Jan 13, 2022
Reduced 4.68%
|
|
Matthew S. Holt
Director |
7,908 | 0 | 7,908 $176,901 | 2 |
May 12, 2022
Added 45.84%
|